Skip to main content


Why Zalicus (ZLCS) Stock Is Surging Today

Zalicus (ZLCS) surged Thursday after Epirus Switzerland announced clinical data from a Phase 3 study of BOW015, a biosimilar infliximab, in patients with active rheumatoid arthritis.

Why Zalicus (ZLCS) Stock Is Soaring Today

Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals. After the all-stock transaction closes, Zalicus will be known as Epirus and will operate under the latter company's management team led by Amit Munshi as president and CEO. Current Zalicus stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ.

3 Stocks Under $10 in Breakout Territory

These under-$10 stocks are within range of triggering major breakout trades.

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

Biotech Trading 2014 Starts Hot, But Surprise, Last Year Was Even Better

The biotech sector has jumped off to a strong start to 2014, with today's blockbuster move in Intercept Pharma offering a big assist. I know it's ridiculously early to make any sort of definitive judgment, but I wondered how the first days of biotech trading 2014 compared to 2013. Here are the charts:

Breaking News

Tesla Stock Slides On Reports of California Layoffs, Office Closure

Tesla has reportedly closed its San Mateo office, and laid off 200 employees, as it begins a wave of cost cuts throughout the carmaker's global operations.

Disney Stock Lower As Board Extends Contract of CEO Bob Chapek

"Bob is the right leader at the right time for The Walt Disney Company, and the board has full confidence in him and his leadership team,' said Disney chair Sue Arnold.

Bed Bath & Beyond Stock Plunges On Q1 Loss, CEO Mark Tritton Exit

"After thorough consideration, the Board determined that it was time for a change in leadership," said independent director Harriet Edelman.

FedEx Stock Slides As Ground Margin Forecast Highlights Inflation Challenge

"Our strategy is focused on driving yields, expanding margins, and elevating returns through profitable growth and capital efficiency," said new CEO Raj Subramaniam.